Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.
Michielan L, Bolcato C, Federico S, Cacciari B, Bacilieri M, Klotz KN, Kachler S, Pastorin G, Cardin R, Sperduti A, Spalluto G, Moro S. Michielan L, et al. Among authors: pastorin g. Bioorg Med Chem. 2009 Jul 15;17(14):5259-74. doi: 10.1016/j.bmc.2009.05.038. Epub 2009 May 21. Bioorg Med Chem. 2009. PMID: 19501513
Medicinal chemistry of A2A adenosine receptor antagonists.
Cacciari B, Pastorin G, Spalluto G. Cacciari B, et al. Among authors: pastorin g. Curr Top Med Chem. 2003;3(4):403-11. doi: 10.2174/1568026033392183. Curr Top Med Chem. 2003. PMID: 12570758 Review.
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G, Da Ros T, Spalluto G, Deflorian F, Moro S, Cacciari B, Baraldi PG, Gessi S, Varani K, Borea PA. Pastorin G, et al. J Med Chem. 2003 Sep 25;46(20):4287-96. doi: 10.1021/jm030852k. J Med Chem. 2003. PMID: 13678407
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.
Moro S, Braiuca P, Deflorian F, Ferrari C, Pastorin G, Cacciari B, Baraldi PG, Varani K, Borea PA, Spalluto G. Moro S, et al. Among authors: pastorin g. J Med Chem. 2005 Jan 13;48(1):152-62. doi: 10.1021/jm049662f. J Med Chem. 2005. PMID: 15634009
A2B adenosine receptor antagonists: recent developments.
Cacciari B, Pastorin G, Bolcato C, Spalluto G, Bacilieri M, Moro S. Cacciari B, et al. Among authors: pastorin g. Mini Rev Med Chem. 2005 Dec;5(12):1053-60. doi: 10.2174/138955705774933374. Mini Rev Med Chem. 2005. PMID: 16375751 Review.
133 results